$CV News

CapsoVision Maps AI Capsule Push Into Colon, Pancreatic Cancer Screening

CapsoVision to Present at the 20th Annual LD Micro Main Event

CapsoVision Announces FDA Clearance of AI Highlights for CapsoCam Plus®

CapsoVision Receives FDA Clearance For Its AI Highlights Reading Tool For The CapsoCam Plus System

CapsoVision Announces Offering Of 3,163,444 Shares Of Common Stock At A Price Of $5.69/Share, Net Proceeds Expected At $17.83M

CapsoVision to Participate in Upcoming Investor Conferences

CapsoVision Inc (CV) (Q2 2026) Earnings Call Highlights: AI Launch Drives Growth Amid Pricing ...

CapsoVision Q2 Earnings Call Highlights

CapsoVision, Inc. (CV) Q2 2026 Earnings Call Transcript

CapsoVision Reports Second Quarter 2026 Financial Results

CapsoVision Q2 2026 Earnings Call Transcript

CapsoVision Files Prospectus For Up To $250M Offering Of Common Stock, Preferred Stock, Warrants, Rights And Units

CapsoVision Enters Sales Agreement With Cantor FitzGerald For ATM Offering Up To $100M

CapsoVision® Announces International Launch of AI Highlights

CapsoVision to Release Second Quarter 2026 Financial Results on August 13, 2026

CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors

CapsoVision Inc (NASDAQ:CV) Q1 2026 Miss Sends Stock Down 8% in After-Hours Trading

CapsoVision Q1 Earnings Call Highlights

CapsoVision Reports First Quarter 2026 Financial Results

CapsoVision, Inc. (CV) Q1 2026 Earnings Call Transcript